Tendon-Bone Interface (Enthesis)

Two Types of Enthesis

Fibrocartilaginous Enthesis:

• Found at sites of high compression (rotator cuff, Achilles, patellar tendon)
• Four-zone structure with fibrocartilage transition
• Contains collagen types I, II, and III
• Has tidemark separating calcified from uncalcified zones

Fibrous (Direct) Enthesis:

• Found where tendons attach at obtuse angles
• No fibrocartilage zones - direct insertion
• Sharpey fibers insert directly into bone
• Examples: Deltoid to humerus, flexor tendons

Clinical Classification of Enthesopathies

By Etiology:

• Degenerative: Chronic overload, aging (rotator cuff, Achilles)
• Inflammatory: Spondyloarthropathies (AS, psoriatic arthritis)
• Traumatic: Acute avulsion injuries

By Location:

• Upper limb: Lateral epicondyle, rotator cuff insertion
• Lower limb: Achilles, plantar fascia, patellar tendon
• Axial: Spinal ligament entheses

Imaging Modalities

Plain Radiographs:

• Enthesophyte formation (chronic traction spurs)
• Calcification within tendon near insertion
• Cortical irregularity at insertion site
• Bone erosion in inflammatory enthesopathy

Ultrasound:

• First-line imaging for enthesopathy
• Thickening of tendon at insertion
• Hypoechogenicity (degeneration)
• Power Doppler: Neovascularity in inflammation
• Cortical irregularity, enthesophytes

MRI Assessment

Key Findings:

• Bone marrow edema adjacent to enthesis (active inflammation)
• Tendon signal changes (degeneration, partial tear)
• Peritendinous fluid
• Complete vs partial tears

Research Imaging:

• T2* mapping for tendon degeneration
• Sodium MRI for proteoglycan content
• Ultrasound elastography for stiffness

Conservative Management

Activity Modification:

• Relative rest from aggravating activities
• Cross-training with low-impact alternatives
• Gradual return to activity when symptoms improve

Physical Therapy:

• Eccentric loading programs (Achilles, patellar tendon)
• Stretching and flexibility
• Strengthening proximal and distal to insertion
• Biomechanical correction (orthotics, footwear)

Pharmacological:

• NSAIDs for pain and inflammation
• Corticosteroid injection (caution near weight-bearing tendons)
• PRP injection (emerging evidence)

Inflammatory Enthesopathy (Spondyloarthropathy)

Systemic Treatment:

• NSAIDs first-line for spondyloarthropathy
• DMARDs (sulfasalazine, methotrexate) for peripheral disease
• Biologics: TNF-alpha inhibitors, IL-17 inhibitors

Local Treatment:

• Corticosteroid injection for isolated enthesitis
• Physical therapy and biomechanical optimization

Tendon-to-Bone Fixation Techniques

Transosseous Repair:

• Tunnels through bone for suture passage
• Good bone-tendon apposition
• Lower cost than anchors

Suture Anchor Repair:

• Anchors placed in bone at insertion footprint
• Single-row or double-row techniques
• Suture bridge constructs maximize footprint coverage

Double-Row Technique:

• Medial row anchors at articular margin
• Lateral row anchors for suture bridge compression
• Improved footprint contact and initial fixation

Biologic Augmentation Strategies

Bone Marrow Stimulation:

• Microfracture or abrasion at footprint
• Recruits mesenchymal stem cells
• Creates healing response at interface

PRP/Growth Factors:

• Applied at tendon-bone interface
• May enhance early healing
• Variable evidence for improved outcomes

Scaffolds:

• Acellular dermal matrix
• Synthetic scaffolds
• Augment repair, especially in retears

Degenerative Enthesopathy Complications

Progression to Complete Rupture:

• Chronic degeneration weakens tendon
• Eventual failure with minimal trauma
• Common at Achilles insertion, rotator cuff

Calcification:

• Calcium deposition in degenerative tissue
• May cause mechanical symptoms
• Calcific tendinitis (rotator cuff)

Post-Repair Complications

Re-tear:

• Most common complication (20-40% for rotator cuff)
• Healing forms scar, not native enthesis
• Biomechanically inferior to native

Failure at Tendon-Bone Interface:

• Suture pullout through tendon
• Anchor pullout from bone
• Interface failure (most common)

Rehabilitation Phases

Phase 1: Protection (0-6 weeks):

• Immobilization or protected motion
• Passive ROM only
• Avoid active contraction of repaired muscle
• Protect healing interface

Phase 2: Early Motion (6-12 weeks):

• Active-assisted motion begins
• Light loading permitted
• Progressive ROM exercises
• Avoid heavy resistance

Optimizing Healing

Mechanical Loading Principles:

• Controlled loading improves collagen organization
• Complete immobilization harmful to enthesis
• Balance protection with beneficial loading

Factors Affecting Rehabilitation:

• Tear size and tissue quality
• Repair construct strength
• Patient compliance and biology
• Smoking, diabetes, age

Healing Biology Outcomes

Native Architecture NOT Restored:

• Healing forms scar tissue at interface
• Fibrocartilage zones do not regenerate
• Collagen organization remains disorganized
• Biomechanical strength 60-80% of native

Clinical Outcomes:

• Pain relief: Generally good (80-90%)
• Functional improvement: Good
• Structural healing: Variable (60-80% intact at 2 years for rotator cuff)

Predictors of Outcome

Positive Factors:

• Smaller tear size
• Better tissue quality
• Younger age
• Non-smoker
• Good compliance with rehabilitation

Negative Factors:

• Large/massive tears
• Fatty infiltration greater than Goutallier 2
• Muscle atrophy
• Revision surgery
• Smoking, diabetes

Global Epidemiology and Guideline Comparison

Enthesis-related disorders are among the commonest musculoskeletal presentations worldwide. Full-thickness rotator cuff tear prevalence rises steeply with age (uncommon under 50, present in roughly a third of those over 60 on imaging, much of it asymptomatic). Achilles, patellar and lateral-epicondyle enthesopathies dominate sports and occupational practice. Inflammatory enthesitis is the defining lesion of spondyloarthropathy (population prevalence of the spectrum approximately 0.5 to 1.5 percent).

Registries and Resource-Setting Variation

• Registry evidence: Shoulder/soft-tissue repairs are less comprehensively captured than arthroplasty, but national shoulder registries (e.g. UK, Nordic, Australian) increasingly track cuff-repair revision and re-operation; biologic-spectrum drug registries (e.g. national biologics registries) inform TNF/IL-17 safety and persistence data for enthesitis.
• High-resource settings: Arthroscopic double-row / suture-bridge repair, MRI staging of fatty infiltration (Goutallier), and image-guided injections are routine; biologics are accessible for spondyloarthropathy.
• Limited-resource settings: Emphasis on structured exercise and open or single-row repair; advanced imaging and biologic DMARDs may be restricted, raising the threshold for surgery and shifting care toward rehabilitation.